Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• Breast cancer therapy failure often stems from impaired cellular metabolism and homeostasis, complicating treatment response prediction.
• Resistance to chemotherapy in breast cancer can arise from abnormalities in the apoptotic pathway.
• Autophagy plays a critical role in cancer development, progression, and treatment response, making it a key research focus.

Purpose of the Study:

• To review current knowledge on breast cancer treatment strategies.
• To focus on drugs targeting pathways and factors involved in autophagy modulation.
• To cover treatments for different breast cancer molecular subtypes.

Main Methods:

• Literature review of approved drugs and their mechanisms.
• Analysis of targeted pathways and factors related to autophagy.
• Synthesis of information on molecular subtypes and associated therapies.

Main Results:

• Identified approved drugs targeting specific molecular subtypes of breast cancer.
• Highlighted the role of autophagy modulation in influencing treatment efficacy.
• Summarized key pathways and factors associated with autophagy in breast cancer.

Conclusions:

• Understanding autophagy modulation is crucial for overcoming breast cancer therapy failure.
• Targeted therapies modulating autophagy offer potential for improved treatment outcomes in diverse breast cancer subtypes.
• Further research into autophagy-regulating drugs can enhance breast cancer treatment strategies.